Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Age and Ageing|December 22, 1999
Falls prevention over 2 years: a randomized controlled trial in women 80 years and olderA J Campbell, M C Robertson, M M Gardner, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|July 27, 1999
Trauma-related hospitalizations among urban adolescents in New Zealand: priorities for preventionS N Ameratunga, C S Alexander, G S Smith, et al.
Gut|December 1, 1982
Treatment of alcohol-related liver disease with thioctic acid: a six month randomised double-blind trialA W Marshall, R S Graul, M Y Morgan, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2000
Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre studyR Williams, O F James, T W Warnes, et al.
Gut|November 1, 1980
Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trialJ C Colman, M Y Morgan, P J Scheuer, et al.
Gut|May 1, 1982
Plasma amino-acid patterns in liver diseaseM Y Morgan, A W Marshall, J P Milsom, et al.
British Journal of Clinical Pharmacology|February 1, 1989
The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.
Clinical Science (London, England : 1979)|April 1, 1988
Caffeine clearance and biotransformation in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.
Gut|March 1, 1985
Cholestatic jaundice in the haemolytic-uraemic syndrome: a case reportG Jeffrey, C C Kibbler, R Baillod, et al.
Advances in Alcohol & Substance Abuse|January 1, 1988
The measurement of D,L-2,3-butanediol in controls and patients with alcoholic cirrhosisJ P Casazza, J Freitas, D Stambuk, et al.
Pageof 9